FR2322605B1 - - Google Patents

Info

Publication number
FR2322605B1
FR2322605B1 FR7626734A FR7626734A FR2322605B1 FR 2322605 B1 FR2322605 B1 FR 2322605B1 FR 7626734 A FR7626734 A FR 7626734A FR 7626734 A FR7626734 A FR 7626734A FR 2322605 B1 FR2322605 B1 FR 2322605B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7626734A
Other versions
FR2322605A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50108197A external-priority patent/JPS5231821A/ja
Priority claimed from JP8061376A external-priority patent/JPS537662A/ja
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Publication of FR2322605A1 publication Critical patent/FR2322605A1/fr
Application granted granted Critical
Publication of FR2322605B1 publication Critical patent/FR2322605B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
FR7626734A 1975-09-05 1976-09-06 Procede pour l'obtention d'une preparation stable du sulfate de dehydroepiandrosterone Granted FR2322605A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50108197A JPS5231821A (en) 1975-09-05 1975-09-05 Method of manufacturing freeze-dried dehydroepiandrosterone sulfate sa lts for injection use
JP8061376A JPS537662A (en) 1976-07-06 1976-07-06 Preparation of injection containing stable dehydroepiandrosterone sulfate

Publications (2)

Publication Number Publication Date
FR2322605A1 FR2322605A1 (fr) 1977-04-01
FR2322605B1 true FR2322605B1 (fr) 1982-08-20

Family

ID=26421606

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7626734A Granted FR2322605A1 (fr) 1975-09-05 1976-09-06 Procede pour l'obtention d'une preparation stable du sulfate de dehydroepiandrosterone

Country Status (15)

Country Link
US (1) US4061744A (fr)
AU (1) AU498543B2 (fr)
CA (1) CA1047404A (fr)
CS (1) CS216160B2 (fr)
DD (1) DD127381A5 (fr)
DE (1) DE2639849A1 (fr)
DK (1) DK153124C (fr)
ES (1) ES451256A1 (fr)
FR (1) FR2322605A1 (fr)
GB (1) GB1561360A (fr)
HU (1) HU173475B (fr)
IL (1) IL50376A (fr)
NL (1) NL183385C (fr)
SE (1) SE439586B (fr)
SU (1) SU1072789A3 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496556A (en) * 1982-08-16 1985-01-29 Norman Orentreich Topical applications for preventing dry skin
JPS63104924A (ja) * 1986-10-20 1988-05-10 Kanebo Ltd 膣坐剤
NL194728C (nl) * 1987-04-16 2003-01-07 Hollis Eden Pharmaceuticals Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan.
JPS6440428A (en) * 1987-08-07 1989-02-10 Daiichi Yakuhin Sangyo Kk Antihyperlipemia
US5246704A (en) * 1989-01-23 1993-09-21 Kanebo, Ltd. Vaginal suppository
JP2546808B2 (ja) * 1989-01-23 1996-10-23 鐘紡株式会社 膣坐剤
US5004651A (en) * 1989-01-24 1991-04-02 Abbott Laboratories Stabilizing system for solid dosage forms
CA2013474C (fr) * 1989-04-20 2000-01-18 Pharmacia Inc. Lyophilisats de cyclophosphamide et d'alanine
US5268368A (en) * 1991-05-17 1993-12-07 Erbamont, Inc. Cyclophosphamide--amino acid lyophilizates
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB957392A (en) * 1961-07-17 1964-05-06 Farmaceutici Italia 16ª‡-hydroxy-steroids
DE1767898A1 (de) * 1967-07-28 1971-09-30 Hoffmann La Roche Verfahren zur Herstellung einer Arzneimittelzubereitung
US4005200A (en) * 1975-07-17 1977-01-25 Kanebo, Ltd. Method for improving the maturity of the parturient canal and the sensitivity to oxytocin

Also Published As

Publication number Publication date
FR2322605A1 (fr) 1977-04-01
SE439586B (sv) 1985-06-24
NL183385C (nl) 1988-10-17
AU1748676A (en) 1978-03-16
IL50376A0 (en) 1976-10-31
SU1072789A3 (ru) 1984-02-07
IL50376A (en) 1979-10-31
DK153124B (da) 1988-06-20
HU173475B (hu) 1979-05-28
DE2639849A1 (de) 1977-03-17
NL7609833A (nl) 1977-03-08
DE2639849C2 (fr) 1987-02-12
ES451256A1 (es) 1977-09-16
CA1047404A (fr) 1979-01-30
US4061744A (en) 1977-12-06
GB1561360A (en) 1980-02-20
DD127381A5 (fr) 1977-09-21
DK396576A (da) 1977-03-06
SE7609443L (sv) 1977-03-06
CS216160B2 (en) 1982-10-29
NL183385B (nl) 1988-05-16
DK153124C (da) 1988-12-19
AU498543B2 (en) 1979-03-15

Similar Documents

Publication Publication Date Title
JPS51104350A (fr)
FR2322605B1 (fr)
IN143043B (fr)
FR2303558B1 (fr)
JPS578086B2 (fr)
JPS51145570U (fr)
JPS51104116U (fr)
CS174662B1 (fr)
JPS5231025U (fr)
CH579485A5 (fr)
CH603802A5 (fr)
BG22517A1 (fr)
CH602904A5 (fr)
BG22905A1 (fr)
CH602909A5 (fr)
CH603151A5 (fr)
CH603355A5 (fr)
CH603702A5 (fr)
CH602835A5 (fr)
BG23245A1 (fr)
CH1397375A4 (fr)
CH603734A5 (fr)
CH577128A5 (fr)
CH600909A5 (fr)
CH582838A5 (fr)